Found: 15
Select item for more details and to access through your institution.
Long-term proliferation of functional human NK cells, with conversion of CD56 NK cells to a CD56 phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 615, doi. 10.1007/s00262-011-1122-3
- By:
- Publication type:
- Article
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 629, doi. 10.1007/s00262-011-1081-8
- By:
- Publication type:
- Article
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 643, doi. 10.1007/s00262-011-1125-0
- By:
- Publication type:
- Article
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 655, doi. 10.1007/s00262-011-1124-1
- By:
- Publication type:
- Article
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 667, doi. 10.1007/s00262-011-1132-1
- By:
- Publication type:
- Article
A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 677, doi. 10.1007/s00262-011-1135-y
- By:
- Publication type:
- Article
The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 689, doi. 10.1007/s00262-011-1129-9
- By:
- Publication type:
- Article
Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 713, doi. 10.1007/s00262-011-1133-0
- By:
- Publication type:
- Article
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 725, doi. 10.1007/s00262-011-1182-4
- By:
- Publication type:
- Article
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 599, doi. 10.1007/s00262-012-1222-8
- By:
- Publication type:
- Article
Scutellaria extract and wogonin inhibit tumor-mediated induction of T cells via inhibition of TGF-β1 activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 701, doi. 10.1007/s00262-011-1130-3
- By:
- Publication type:
- Article
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 5, p. 733, doi. 10.1007/s00262-012-1227-3
- By:
- Publication type:
- Article
Comment on 'Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy' by Gustav J. Ullenhag et al.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Response to the letter to the editors from Inge Marie Svane on our manuscript 'Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy'.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
- Published in:
- 2012
- By:
- Publication type:
- Report